Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UPDATE: Consideration Includes ~$1.1M In Carmell Common Stock, ~$57K In Cash Upon Sale Of Specified Inventory And Contingent Earnout

Author: Benzinga Newsdesk | January 02, 2025 08:05am

The purchase consideration for the Acquisition is as follows:

  • Approximately $1.1 million in Carmell common stock at the closing of the Acquisition (the "Closing");
  • Approximately $57,000 in cash upon the sale of specified inventory existing as of the Closing;
  • Contingent earnout consideration consisting of:
    • 5% of net sales from Elevai's existing products paid annually during the 5-year period following the Closing, and
    • a one-time milestone payment of $500,000 if Elevai's hair and scalp products achieve $500,000 in net revenue within 24 months following the Closing; and
  • Carmell's assumption of contractual liabilities and trade payables of Elevai at the Closing.

Posted In: CTCX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist